Biotech

All Articles

Takeda takes $140M reduction on fallen short epilepsy medication, promotes FDA manage

.Our company presently know that Takeda is actually hoping to find a pathway to the FDA for epilepsy...

VBI Injections apply for insolvency, looks for possession sale

.Immunology biotech VBI Vaccines is veering precariously close to the climax, along with programs to...

Celldex anti-cKIT antibody lessen hives in an additional stage 2 research study

.It's difficult to muscular tissue in on a space as reasonable as immunology, but Celldex Rehabs fee...

Boehringer offers up to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapies and also a preclinical immune...

Ventyx's last resort for inflamed med sides in Crohn's failure

.Ventyx Biosciences' Crohn's ailment medication performed certainly not assist people achieve remiss...

Cognition's phase 2 sparkle data tarnish Alzheimer's prospect

.Knowledge Therapies' stage 2 SHINE test has actually taken several of the luster off the Alzheimer'...

BMS axes bispecific months after filing to operate period 3 test

.Bristol Myers Squibb has possessed a whiplash change of heart on its BCMA bispecific T-cell engager...

Charles Baum manages Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., that managed Mirati Therapies' $ 5.8 billion sale to Bristol Myers Squib...

Asarina to shut after efforts to companion Tourette's medicine neglect

.After communicating to more than 200 providers to partner a Tourette syndrome therapy that revealed...

Novartis pens $150M in advance bispecifics deal with Dren Bio

.Novartis has had some misfortune along with bispecific antibodies before, but evaluating by the pha...